DJIA 17,712.66 34.43 0.19%
NASDAQ 4,891.22 27.86 0.57%
S&P 500 2,061.02 4.87 0.24%
market minute promo

175.42 2.03 (1.17%)

REAL-TIME: Last trade at

Extended Hours: $175.42 $0.00 (0.00%)
Quote as of (NASDAQ)

company name or ticker

Recent Quotes

JAZZ $175.42 1.17%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $173.57
Previous Close $173.39
Daily Range $173.57 - $177.49
52-Week Range $120.38 - $190.17
Market Cap $10.6B
P/E Ratio 186.44
Dividend (Yield) $0.00 (0.0%)
Volume 618,110
Average Daily Volume 813,504
Current FY EPS $8.88




Drug Makers

Jazz Pharmaceuticals, Inc. (JAZZ) Description

A specialty pharmaceutical company, which focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. Website:

News & Commentary Rss Feed

Pfizer Inc. Has a Growth Problem -- Here Are 3 Ways to Change That

This year will likely mark Pfizer's fifth consecutive year of revenue declines. But a quick solution to its growth concerns could lie within one (or more) of these three proposed fixes.

Weekly Insider Sells Highlight: MHK, JAZZ, BMY, ZAYO

Insider Trading Alert - CTSH, VNTV And JAZZ Traded By Insiders Daily Round Up 3/20/15: DRRX, RWC, GEF.B, MRD

New Lifetime High Reached: Jazz Pharmaceuticals (JAZZ)

Oppenheimer: Bullish Technical Analysis Of 5 Healthcare Names

Jazz Pharmaceuticals (JAZZ) Upgraded From Hold to Buy

Jazz Pharmaceuticals Up on U.S. Approval of Xyrem REMS - Analyst Blog

Jazz Pharmaceuticals Is Undervalued

Play This "Hidden" M&A Boom – and Beat the Market for the Next Two Years

See More JAZZ News...

JAZZ's Top Competitors

JAZZ $175.42 (1.17%)
Current stock: JAZZ
JNJ $100.34 (0.20%)
Current stock: JNJ
NVS $100.40 (0.84%)
Current stock: NVS
RHHBY $34.25 (-0.23%)
Current stock: RHHBY